These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26503151)

  • 1. Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases.
    Tyler PD; Kang PM
    Curr Pharm Des; 2015; 21(42):6070-80. PubMed ID: 26503151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular nanomedicine: the route ahead.
    Iafisco M; Alogna A; Miragoli M; Catalucci D
    Nanomedicine (Lond); 2019 Sep; 14(18):2391-2394. PubMed ID: 31456471
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanomedicine applied to cardiovascular diseases: latest developments.
    Martín Giménez VM; Kassuha DE; Manucha W
    Ther Adv Cardiovasc Dis; 2017 Apr; 11(4):133-142. PubMed ID: 28198204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.
    Arshad I; Kanwal A; Zafar I; Unar A; Mouada H; Razia IT; Arif S; Ahsan M; Kamal MA; Rashid S; Khan KA; Sharma R
    Environ Res; 2024 Feb; 242():117795. PubMed ID: 38043894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
    Kim KS; Song CG; Kang PM
    Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guest Editor John Cooke Offers Expertise and Insight on Nanotherapeutic Solutions for Cardiovascular Diseases.
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):131. PubMed ID: 27826364
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases.
    Saeed S; Ud Din SR; Khan SU; Gul R; Kiani FA; Wahab A; Zhong M
    Curr Probl Cardiol; 2023 May; 48(5):101599. PubMed ID: 36681209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
    Godin B; Sakamoto JH; Serda RE; Grattoni A; Bouamrani A; Ferrari M
    Trends Pharmacol Sci; 2010 May; 31(5):199-205. PubMed ID: 20172613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology and atherosclerosis imaging: emerging diagnostic and therapeutic applications.
    Schoenhagen P; Conyers JL
    Recent Pat Cardiovasc Drug Discov; 2008 Jun; 3(2):98-104. PubMed ID: 18537760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine in cardiovascular therapy: recent advancements.
    Binsalamah ZM; Paul A; Prakash S; Shum-Tim D
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):805-15. PubMed ID: 22894635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotherapeutic Solutions for Cardiovascular Disease.
    Cooke JP; Atkins J
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):132-133. PubMed ID: 27826365
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of Nanotechnology for Diagnosis and Drug Delivery in Atherosclerosis: A New Horizon of Treatment.
    Lankala CR; Yasir M; Ishak A; Mekhail M; Kalyankar P; Gupta K
    Curr Probl Cardiol; 2023 Jun; 48(6):101671. PubMed ID: 36828044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness.
    Douma K; Megens RT; van Zandvoort MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):376-88. PubMed ID: 21448988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticles: the future of nanomedicine.
    Banik BL; Fattahi P; Brown JL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):271-99. PubMed ID: 26314803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-medicine and Vascular Endothelial Dysfunction: Options and Delivery Strategies.
    Taneja G; Sud A; Pendse N; Panigrahi B; Kumar A; Sharma AK
    Cardiovasc Toxicol; 2019 Feb; 19(1):1-12. PubMed ID: 30448914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases.
    Sharma PA; Maheshwari R; Tekade M; Tekade RK
    Curr Pharm Des; 2015; 21(30):4465-78. PubMed ID: 26354926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergence of nanotechnology and cardiovascular medicine : progress and emerging prospects.
    Iverson N; Plourde N; Chnari E; Nackman GB; Moghe PV
    BioDrugs; 2008; 22(1):1-10. PubMed ID: 18215086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.